Antidepressants prescribed to children should carry a clearly stated warning that they can sometimes trigger suicidal thoughts or actions in pediatric patients.That was the unanimous recommendation handed up Tuesday by members of two U.S. Food and Drug Administration panels convened jointly to examine the risks of giving medications known as selective serotonin reuptake inhibitors to children, according to wire service reports.The 25-0 vote, which was greeted with applause by tearful families at the hearing, followed two days of testimony in Washington, D.C., and mounting evidence that antidepressants like Paxil, Prozac and Zoloft may induce suicide or suicidal thoughts in some children.
